logo
Select company
Select metric
41.68%Cash to Assets Ratio
VS
Market
89
Sector
67
Industry
56
History
-
$ 8.76Close
$ 3.99 - $ 9.88 52-Week Range
Ticker Information

Ticker

FENC

Company Name

FENNEC PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

FENNEC PHARMACEUTICALS INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

FENC - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 44.88M$ 18.7M41.68%
3/31/2025$ 46.4M$ 22.68M48.87%
12/31/2024$ 44.95M$ 26.63M59.26%
9/30/2024$ 58.92M$ 40.32M68.43%
6/30/2024$ 63.16M$ 43.05M68.17%
3/31/2024$ 69.19M$ 51.18M73.97%
12/31/2023$ 26.86M$ 13.27M49.39%
9/30/2023$ 19.03M$ 12.4M65.16%
6/30/2023$ 19.44M$ 14.96M76.96%
3/31/2023$ 21.82M$ 18.39M84.28%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • FENNEC PHARMACEUTICALS INC's latest trailing twelve months (TTM) Cash to Assets stands at 97.35%.
  • Over the past 5 years, FENNEC PHARMACEUTICALS INC's average Cash to Assets has been 79.41%.
  • The median Cash to Assets for FENNEC PHARMACEUTICALS INC during this period was 86.26%
  • FENNEC PHARMACEUTICALS INC reached its highest Cash to Assets over the past 5 years at 97.81%.
  • The lowest Cash to Assets recorded by FENNEC PHARMACEUTICALS INC in the same timeframe 41.68%

FENNEC PHARMACEUTICALS INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
CCCC : C4 THERAPEUTICS INC 27.52%VYGR : VOYAGER THERAPEUTICS INC 14.53%EDIT : EDITAS MEDICINE INC 65.79%OABI : OMNIAB INC 6.37%FHTX : FOGHORN THERAPEUTICS INC 33.51%SCPH : SCPHARMACEUTICALS INC 50.85%STXS : STEREOTAXIS INC 16.92%LCTX : LINEAGE CELL THERAPEUTICS INC 46.55%MGX : METAGENOMI INC 11.79%MXCT : MAXCYTE INC 6.93%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for FENNEC PHARMACEUTICALS INC is calculated as follows: CashnEq [ $ 33.17M ] / Assets [ $ 34.07M ]
(=) Cash to Assets [ 97.35% ]

FENC - Cash to Assets Ratio, Last 5 years

41.68%

Minimum

Jun 30, 2025

97.81%

Maximum

Sep 30, 2022

79.41%

Average

86.26%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.79% with a standard deviation of 9.55%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.8%
average9.79%
median6.44%
std9.55%